✦ LIBER ✦

Multinational cooperation in trials and guidelines dealing with febrile neutropenia

✍ Scribed by Ronald Feld

Book ID: 119563082
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 57 KB
Volume: 16
Category: Article
ISSN: 0924-8579
DOI: 10.1016/s0924-8579(00)00240-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Design of Clinical Trials of Empiric Ant

Design of Clinical Trials of Empiric Antifungal Therapy in Patients with Persistent Febrile Neutropenia: Considerations and Critiques

✍ Jack D. Sobel 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

A randomized clinical trial of ceftriaxo

A randomized clinical trial of ceftriaxone and amikacin versus piperacillin tazobactam and amikacin in febrile patients with hematological neoplasia and severe neutropenia

✍ Fausto Rossini; Elisabetta Terruzzi; Luisa Verga; Alessandra Larocca; Sara Marin 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 83 KB

3509 POSTER Febrile Neutropenia Rates Wi

3509 POSTER Febrile Neutropenia Rates With Common Chemotherapy Regimens in Randomized Controlled Trials Compared With Non-randomized Cohort Studies – a Systematic Review and Meta-regression

✍ C. Freedman; M. Trudeau; G. Tomlinson; K. Chan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 39 KB

CEFEPIME VERSUS CETAZIDIME+AMIKACIN AS E

CEFEPIME VERSUS CETAZIDIME+AMIKACIN AS EMPIRICAL THERAPY FOR FEBRILE NEUTROPENIA IN CHILDREN WITH CANCER: A Prospective Randomized Trial of the Treatment Efficacy and Cost

✍ Çorapçioglu, Funda; Sarper, Nazan 📂 Article 📅 2005 🏛 Informa plc 🌐 English ⚖ 132 KB

Results of a Multicenter, Controlled, Ra

Results of a Multicenter, Controlled, Randomized Clinical Trial Evaluating the Combination of Piperacillin/Tazobactam and Tigecycline in High-Risk Hematologic Patients With Cancer With Febrile Neutropenia

✍ Bucaneve, G.; Micozzi, A.; Picardi, M.; Ballanti, S.; Cascavilla, N.; Salutari, 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 250 KB

EORTC guidelines for the use of granuloc

EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours

✍ M.S. Aapro; D.A. Cameron; R. Pettengell; J. Bohlius; J. Crawford; M. Ellis; N. K 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 309 KB